Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Sex-specific resting state brain network dynamics in patients with major depressive disorder
    Published on 2024-01-12
    2 years ago
  • Amplitude-determined seizure-threshold, electric field modeling, and electroconvulsive therapy antidepressant and cognitive outcomes
    Published on 2024-01-10
    2 years ago
  • Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?
    Published on 2024-01-10
    2 years ago
  • Effects of open access publishing on article metrics in Neuropsychopharmacology
    Published on 2024-01-10
    2 years ago
  • Correction: The effects of experience of discrimination and acculturation during pregnancy on the developing offspring brain
    Published on 2024-01-10
    2 years ago
  • Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder
    Published on 2024-01-09
    2 years ago
  • Neurogenesis-independent mechanisms of MRI-detectable hippocampal volume increase following electroconvulsive stimulation
    Published on 2024-01-08
    2 years ago
« Previous 1 … 92 93 94 95 96 … 143 Next »
Journal of Psychopharmacology
  • Discontinuation and relapse with paliperidone palmitate three-monthly for maintenance of schizophrenia: Two year follow-up of use in clinical practice
    Published on 2021-04-28
    5 years ago
  • Easier patient access to medical cannabis carries risks as well as benefits
    Published on 2021-04-28
    5 years ago
  • Hydrocortisone as an adjunct to brief cognitive-behavioural therapy for specific fear: Endocrine and cognitive biomarkers as predictors of symptom improvement
    Published on 2021-04-28
    5 years ago
  • Preliminary evidence for the phosphodiesterase type-4 inhibitor, roflumilast, in ameliorating cognitive flexibility deficits in patients with schizophrenia
    Published on 2021-04-28
    5 years ago
  • Why should pharmacological trials in schizophrenia employ functional magnetic resonance imaging (fMRI)?
    Published on 2021-04-28
    5 years ago
  • Antidepressant action of transcranial direct current stimulation in olfactory bulbectomised adolescent rats
    Published on 2021-04-28
    5 years ago
  • Specific changes in sleep oscillations after blocking human metabotropic glutamate receptor 5 in the absence of altered memory function
    Published on 2021-04-26
    5 years ago
« Previous 1 … 92 93 94 95 96 … 145 Next »
European Neuropsychopharmacology
  • A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response
    Published on 2021-11-27
    4 years ago
  • Emotional cognition in depression: Is it relevant for Clinical practice?
    Published on 2021-11-26
    5 years ago
  • Null effect of vortioxetine augmentation with celecoxib should not be generalized to other antidepressants
    Published on 2021-11-24
    5 years ago
  • Coping under stress: Prefrontal control predicts stress burden during the COVID-19 crisis
    Published on 2021-11-22
    5 years ago
  • Suicide-related thoughts and behavior and suicide death trends during the COVID-19 in the general population of Catalonia, Spain: SUICIDAL BEHAVIOR AND DEATH DURING COVID-19 IN CATALONIA
    Published on 2021-11-20
    5 years ago
  • Imaging of astrocytes in posttraumatic stress disorder: A PET study with the monoamine oxidase B radioligand [11C]SL25.1188
    Published on 2021-11-11
    5 years ago
  • Stratified psychiatry: Tomorrow’s precision psychiatry?
    Published on 2021-11-10
    5 years ago
« Previous 1 … 92 93 94 95 96 … 166 Next »

   Pharma Pub